Search

everythinglearnresearchcommunity

for

Search:↓

The article concludes that different types of hair loss require specific treatments and psychological support is important.

Nonobese, normotensive Indian women with PCOS may have a higher risk of heart problems linked to inflammation and insulin resistance.

The document concludes that managing skin conditions during pregnancy is important and requires specialized care.

Experts agree that PCOS affects women's health in complex ways, but more research is needed to understand and treat it effectively.

New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.

Metformin combined with lifestyle changes improves insulin resistance and reduces testosterone levels in women with PCOS more than lifestyle changes alone.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Hormones affect skin aging and fat distribution, and treatments can help, but only minoxidil is proven for female hair loss.

Acne and increased body hair in teenage girls are normal but severe cases may need hormone evaluation and treatment can prevent diabetes linked to PCO.

Good nutrition is crucial for healthy hair and can help with hair loss without medication.

A woman's adrenal tumor disappeared after treatment with cyproterone acetate.

SHBG may be a useful early indicator and treatment target for PCOS.

Combining yoga and certain herbs can effectively manage PCOS symptoms and improve quality of life.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Androgens play a key role in causing PCOS (Polycystic Ovary Syndrome).

The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.

People with androgenetic alopecia, both men and women, are more likely to develop heart diseases in the future.

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.

Statins may help treat PCOS by lowering androgen levels and improving cholesterol.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

Lifestyle changes like a healthy diet, exercise, and proper sleep can help manage PCOD.

Diagnosing and treating PCOS in teenagers is difficult, and the focus is on lifestyle changes and medication to improve health and prevent future issues.

Kelulut Honey can help regulate sex hormone receptors in rats with Polycystic Ovary Syndrome, similar to common medications.

Some lesser-known causes of PCOS include autoimmune issues, genetic mutations, and changes in the body's microbiome.